1. Home
  2. MESO vs CODI Comparison

MESO vs CODI Comparison

Compare MESO & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MESO
  • CODI
  • Stock Information
  • Founded
  • MESO 2004
  • CODI 2005
  • Country
  • MESO Australia
  • CODI United States
  • Employees
  • MESO N/A
  • CODI N/A
  • Industry
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • CODI Home Furnishings
  • Sector
  • MESO Health Care
  • CODI Consumer Discretionary
  • Exchange
  • MESO Nasdaq
  • CODI Nasdaq
  • Market Cap
  • MESO 2.0B
  • CODI 1.6B
  • IPO Year
  • MESO N/A
  • CODI 2006
  • Fundamental
  • Price
  • MESO $18.04
  • CODI $21.37
  • Analyst Decision
  • MESO Buy
  • CODI Strong Buy
  • Analyst Count
  • MESO 4
  • CODI 3
  • Target Price
  • MESO $13.50
  • CODI $29.00
  • AVG Volume (30 Days)
  • MESO 828.2K
  • CODI 199.0K
  • Earning Date
  • MESO 02-28-2025
  • CODI 02-26-2025
  • Dividend Yield
  • MESO N/A
  • CODI 4.69%
  • EPS Growth
  • MESO N/A
  • CODI 38.85
  • EPS
  • MESO N/A
  • CODI 0.56
  • Revenue
  • MESO $5,902,000.00
  • CODI $2,216,497,000.00
  • Revenue This Year
  • MESO $65.99
  • CODI $12.78
  • Revenue Next Year
  • MESO $425.77
  • CODI $9.73
  • P/E Ratio
  • MESO N/A
  • CODI $37.86
  • Revenue Growth
  • MESO N/A
  • CODI 16.71
  • 52 Week Low
  • MESO $1.72
  • CODI $19.76
  • 52 Week High
  • MESO $22.00
  • CODI $25.07
  • Technical
  • Relative Strength Index (RSI)
  • MESO 59.20
  • CODI 36.07
  • Support Level
  • MESO $15.92
  • CODI $21.11
  • Resistance Level
  • MESO $17.67
  • CODI $21.82
  • Average True Range (ATR)
  • MESO 1.38
  • CODI 0.53
  • MACD
  • MESO -0.37
  • CODI -0.11
  • Stochastic Oscillator
  • MESO 37.14
  • CODI 25.56

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: